An Australian stem cell and regenerative medicine company

July 26, 2023

Dr Kilian Kelly interviewed by Proactive Investors following strategic review

Following the completion of a strategic review of Cynata’s clinical development portfolio, CEO Dr Kilian Kelly sat down with Proactive Investors to discuss the review and his direction for the Company. Watch the interview here.

Or read more about it on the Cairns Post here.